Sherene Loi, MBBS, FRACP, PhD, FAHMS, head of translational breast cancer genomics and therapeutics lab at the University of Melbourne, and Virginia Kaklamani, MD, leader of the breast medical oncology program at Mays Cancer Center at UT Health San Antonio, discuss the options of treating ER positive breast with immunotherapy.
▷ Estimated Read Time:
1–2 minutes
SABCS Snippets: Immunology in hormone receptor positive breast cancer
Join the global breast cancer community for four days of research spanning experimental biology, etiology, translational science, prevention, diagnosis and treatment, December 8-11 in San Antonio, Texas.
Share: